Bennie, Marion; Santa‐ana‐tellez, Yared; Galistiani, Githa Fungie; Trehony, Julien; Despres, Johanna; Jouaville, Laurence Sophie; Poluzzi, Elisabetta; Morin, Lucas; Schubert, Ingrid; Macbride‐stewart, Seán; Elseviers, Monique; Nasuti, Paola; Taxis, Katja, The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2024, 90, pp. 2124 - 2136 [articolo]Open Access
Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E., Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System, «DRUG SAFETY», 2024, 47, pp. 1275 - 1292 [articolo]Open Access
Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E., Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct, «ADDICTION», 2023, 118, pp. 763 - 770 [articolo]Open Access
Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta, Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach, «DRUG SAFETY», 2023, 46, pp. 921 - 926 [articolo]
Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E., Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, «DRUG SAFETY», 2023, 46, pp. 283 - 295 [articolo]Open Access
Noguchi Y.; Yan M.; Yokoyama S.; Poluzzi E., Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology, «FRONTIERS IN PHARMACOLOGY», 2023, 14, pp. 1225909 - 1225910 [replica/breve intervento]Open Access
Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M.; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E., Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, «PSYCHIATRY AND CLINICAL NEUROSCIENCES», 2023, 77, pp. 160 - 167 [articolo]Open Access
Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R., Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System, «JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH», 2023, 66, pp. 3242 - 3259 [articolo]Open Access
DiVito L.; Mazzoni S.; Belotti L.M.B.; Poluzzi E.; Baldin E.; Zenesini C.; Bisulli F.; Tinuper P.; Mostacci B., Impact of regulatory restrictions on the use of valproic acid in women of childbearing age: An Italian study, «EPILEPSIA», 2023, 64, pp. 910 - 918 [articolo]
Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E.; Khouri C., Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study, «DRUG SAFETY», 2023, 46, pp. 857 - 866 [articolo]Open Access
Zito S.; Poluzzi E.; Pierantozzi A.; Onder G.; Da Cas R.; Ippoliti I.; Lunghi C.; Cangini A.; Trotta F., Medication use in Italian nursing homes: preliminary results from the national monitoring system, «FRONTIERS IN PHARMACOLOGY», 2023, 14, Article number: 1128605, pp. 1 - 10 [articolo]Open Access
Ahmadizar F.; Luxi N.; Raethke M.; Schmikli S.; Riefolo F.; Saraswati P.W.; Bucsa C.; Osman A.; Liddiard M.; Maques F.B.; Petrelli G.; Sonderlichova S.; Thurin N.H.; Villalobos F.; Trifiro G.; Sturkenboom M.; Moretti U.; Bellitto C.; Ciccimarra F.; Gonella L.A.; Arzenton E.; Chiamulera C.; Lora R.; Bellantuono D.; Sabaini A.; Firenze A.; Zodda D.; Guidotti F.; Zappone M.; Alagna B.; Cutroneo P.M.; Minore C.; Costantino C.; Vitale F.; D'Alessandro G.; Morreale I.; Marsala L.; Farinella D.; Bavetta S.; Fantini M.P.; Reno C.; Raschi E.; Poluzzi E.; Sapigni E.; Potenza A.M.; Podetti D.; Nikitina V.; Ricciardelli R.; Mogheiseh N.; Croce S.; Paltrinieri B.; Castellani S.; Sangiorgi E.; Selleri M.; Lucchesi S.; Catucci G.; Savini D.; Sacripanti C.; Faccioli M.; Romio M.S.; Rossi L.; Radici S.; Negri G.; Fares L.; Ajolfi C.; Fadda A.; Chiarello A.; Pieraccini F.; Gavioli B.; Palazzi S.; Tuccori M.; Vannacci A.; Bonaiuti R.; Ravaldi C.; Lombardi N.; Crescioli G.; Gori F.; Tessari R.; Zandona E, Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials, «DRUG SAFETY», 2023, 46, pp. 575 - 585 [articolo]Open Access
Raschi, Emanuel; Poluzzi, Elisabetta; De Ponti, Fabrizio, Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 2365 - 2368 [replica/breve intervento]
Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Poluzzi E., The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 2020 - 2027 [articolo]Open Access
Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; Poluzzi E.; Pagotto U.; Di Dalmazi G., Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, «CANCERS», 2022, 14, Article number: 4610, pp. 1 - 13 [articolo]Open Access
